hta in developing countries

HTAi 2020 Annual Meeting

2020 HTAi HTA IN DEVELOPING COUNTRIES INTEREST GROUP ANNUAL BUSINESS MEETING

This Annual Business Meeting is a requirement and part of the activities mandated by the Developing Interest Group.

The meeting shall be an interactive session that will bring together as many members of the interest group in good standing to discuss several topics concerning the group.

The agenda includes, but is not limited to the following

1. Welcome

2. Approval of minutes from Business Meeting 2019

3. Report back from HTAi IG Steering Committee meetings

4. IG activities in preparation for next Annual Meeting 2021 to be held in Manchester

5. Other Business

Regional Projects

DCIG newsletter

In lieu of a physical meeting this year due to the global COVID-19 pandemic, this meeting shall be held virtually.

DATE:

August 11, 2020

TIME:

08:00 – 09:00 MDT (UTC -6)

VIEW THE RECORDING

Upcoming Webinars

HTA Informing Innovative Drugs’ Market Access in Low- and Middle-Income Countries

Join us for a live webinar presented by HTA in Developing Countries Interest Group (DCIG) “HTA Informing Innovative Drugs’ Market Access in Low- and Middle-Income Countries” on December 2, 3:00 a.m. MST (10:00 a.m. UTC).

The WHO identifies achieving Universal Health Coverage (UHC) as a strategic priority, encompassing a full range of essential health services, of which technology constitutes a core component. It is a significant challenge for many countries, especially low- and middle-income countries (LMICs), to increase their use of scarce public resources to ensure their citizens’ access to innovative pharmaceuticals. The dilemma of high costs, limited access, and UHC calls for innovative approaches and solutions.

This webinar demonstrates how HTA informs innovative drugs market access in different LMICs, and it could address how HTA researchers or HTA institutions respond to the innovative technology with capacity competency. It is a pilot to facilitate HTA communication and collaboration by DCIG. It will map market entry, reimbursement policy for innovative drugs and HTA roles, value frameworks and methodology, institutional challenges, and potential regional/international HTA collaboration.

Speakers will present innovative drugs market entry and reimbursement in different continents, analyzing how HTA is conducted and the value frameworks used in different countries. It will summarize challenges to HTA capacity or competency and information shared with other countries for reference

  • Moderator: Yingyao Chen
  • Jeonghoon, from Korea, Korea experience
  • Debora Aligieri (Patient representative Brazil)
  • Salome Meyer (Patient representative, Cancer Association, South Africa)
  • Kiusiang Tay-Teo, (Health Products Policy and Standards Medicines and Health Products, WHO.
  • Mouna Jameleddine, INEAS, Tunisia

Join us live on Youtube

HTAi 2020 Annual Meeting

2020 HTAi HTA IN DEVELOPING COUNTRIES INTEREST GROUP ANNUAL BUSINESS MEETING

This Annual Business Meeting is a requirement and part of the activities mandated by the Developing Interest Group.

The meeting shall be an interactive session that will bring together as many members of the interest group in good standing to discuss several topics concerning the group.

The agenda includes, but is not limited to the following

1. Welcome

2. Approval of minutes from Business Meeting 2019

3. Report back from HTAi IG Steering Committee meetings

4. IG activities in preparation for next Annual Meeting 2021 to be held in Manchester

5. Other Business

Regional Projects

DCIG newsletter

In lieu of a physical meeting this year due to the global COVID-19 pandemic, this meeting shall be held virtually.

DATE:

August 11, 2020

TIME:

08:00 – 09:00 MDT (UTC -6)

VIEW THE RECORDING

Upcoming Webinars

HTA Informing Innovative Drugs’ Market Access in Low- and Middle-Income Countries

Join us for a live webinar presented by HTA in Developing Countries Interest Group (DCIG) “HTA Informing Innovative Drugs’ Market Access in Low- and Middle-Income Countries” on December 2, 3:00 a.m. MST (10:00 a.m. UTC).

The WHO identifies achieving Universal Health Coverage (UHC) as a strategic priority, encompassing a full range of essential health services, of which technology constitutes a core component. It is a significant challenge for many countries, especially low- and middle-income countries (LMICs), to increase their use of scarce public resources to ensure their citizens’ access to innovative pharmaceuticals. The dilemma of high costs, limited access, and UHC calls for innovative approaches and solutions.

This webinar demonstrates how HTA informs innovative drugs market access in different LMICs, and it could address how HTA researchers or HTA institutions respond to the innovative technology with capacity competency. It is a pilot to facilitate HTA communication and collaboration by DCIG. It will map market entry, reimbursement policy for innovative drugs and HTA roles, value frameworks and methodology, institutional challenges, and potential regional/international HTA collaboration.

Speakers will present innovative drugs market entry and reimbursement in different continents, analyzing how HTA is conducted and the value frameworks used in different countries. It will summarize challenges to HTA capacity or competency and information shared with other countries for reference

  • Moderator: Yingyao Chen
  • Jeonghoon, from Korea, Korea experience
  • Debora Aligieri (Patient representative Brazil)
  • Salome Meyer (Patient representative, Cancer Association, South Africa)
  • Kiusiang Tay-Teo, (Health Products Policy and Standards Medicines and Health Products, WHO.
  • Mouna Jameleddine, INEAS, Tunisia

Join us live on Youtube

HTAi is The ONLY Global Society Championing Equitable, Responsive, And Cutting-Edge Health Technology Assessment (HTA). As a community of multidisciplinary advisors, academics, scientists, professionals, public & private organizations, students, and citizen members.Everything we do is dedicated to better health for all people and the future of HTA worldwide.

Become A Member Today

    Copyright © 2021. All Rights Reserved.

HTAi is The ONLY Global Society Championing Equitable, Responsive, And Cutting-Edge Health Technology Assessment (HTA). As a community of multidisciplinary advisors, academics, scientists, professionals, public & private organizations, students, and citizen members.Everything we do is dedicated to better health for all people and the future of HTA worldwide.

Become A Member Today

    Copyright © 2021. All Rights Reserved.